Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Value HR Co.,Ltd. (6078.T)
Tokyo, JP
Established in Tokyo, Japan, in 2001, Value HR Co.,Ltd. specializes in providing a wide array of healthcare services. The company is primarily involved in the conceptualization, development, operation, and administration of its Value Cafeteria welfare support system. For businesses, Value HR offers consultancy on establishing health insurance associations, industrial health services, welfare programs, and acts as an agent for medical checkups. Additionally, it supports health insurance societies and health checkup facilities with administrative outsourcing, temporary staffing solutions, health management and data analytics assistance, probate services, and electronic application system implementation. The company further provides bespoke systems, including a web-based metabo countermeasure support system, a stress check system, and a medical expense itemization notification system.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.71% | -0.57% | -4.58% | -1.62% | -19.07% | -8.82% | -10.46% | -7.00% | +68.29% | +550.42% | +567.75% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+20.2% ★ Q1'26: +12.6% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%-20.5% Q1'26: -18.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+12.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+8.8% Q1'26: +7.7% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+8.7% ★ Q1'26: +5.8% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%0.0% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×3.77× Q1'26: 4.45× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
|---|---|---|---|---|---|---|
| Revenue |
2.24B
est: 2.28B (-1.8%)
|
2.57B
est: 2.73B (-5.8%)
|
2.99B
est: 3.25B (-7.9%)
|
4.28B
est: 4.35B (-1.5%)
|
4.49B
est: 5.10B (-11.9%)
|
5.53B
est: 5.90B (-6.3%)
|
| EBITDA |
426.31M
est: 522.90M (-18.5%)
|
496.03M
est: 626.10M (-20.8%)
|
549.78M
est: 745.36M (-26.2%)
|
900.93M
est: 997.64M (-9.7%)
|
894.88M
est: 1.17B (-23.5%)
|
1.30B
est: 1.35B (-3.6%)
|
| EBIT |
331.38M
est: 415.08M (-20.2%)
|
395.62M
est: 497.00M (-20.4%)
|
436.62M
est: 591.67M (-26.2%)
|
748.43M
est: 791.93M (-5.5%)
|
713.22M
est: 928.47M (-23.2%)
|
1.01B
est: 1.07B (-5.6%)
|
| Net Income |
222.55M
est: 256.79M (-13.3%)
|
215.54M
est: 403.77M (-46.6%)
|
297.41M
est: 538.36M (-44.8%)
|
553.12M
est: 555.10M (-0.4%)
|
460.10M
est: 691.03M (-33.4%)
|
662.56M
est: 815.57M (-18.8%)
|
| SGA |
591.98M
est: 502.43M (+17.8%)
|
662.71M
est: 601.59M (+10.2%)
|
774.80M
est: 716.18M (+8.2%)
|
966.25M
est: 958.58M (+0.8%)
|
996.71M
est: 1.12B (-11.3%)
|
1.23B
est: 1.30B (-5.8%)
|
| EPS |
10.20
est: 9.59 (+6.4%)
|
9.65
est: 15.08 (-36.0%)
|
13.07
est: 20.10 (-35.0%)
|
23.40
est: 20.73 (+12.9%)
|
19.40
est: 25.80 (-24.8%)
|
27.64
est: 30.45 (-9.2%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-14 | B | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gentaro Fujita | Executive Vice President & Director | — | male |
| Hiroo Seki | Executive Officer, Head of Information Systems Division and GM of Info Security & Compliance Office | — | — |
| Isao Iizuka | EVP, Head of Healthcare Business Division & Director | — | male |
| Keiji Kikuchi | Managing Executive Officer and GM of Health Management & Data Health Promotion Office | — | — |
| Michio Fujita | Chairman, President, CEO & Head of Cafeteria Business Division | — | male |
| Miyako Yamazaki | Executive Officer & GM of Women's Empowerment Promotion Office | — | — |
| Naoto Takahashi | Head of Sales Division | — | — |
| Yoji Otani | Managing Executive Officer | — | — |
| Yoshie Endo | General Manager of Business Administration Division | — | — |
| Yuji Ohmura | MD, Chief Information Officer, Head of Information Security and Compliance & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6078.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
